Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Otsuka Pharmaceutical Development & Commercialization, Inc.

4 clinical trials · 4 recruiting · INDUSTRY

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Otsuka Pharmaceutical Development & Commercialization, Inc.

RECRUITINGPhase 3NCT06973577

P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety

Primary: To evaluate the efficacy of CTN in adults ages with ADHD and comorbid anxiety (AISRS) Key Secondary: To assess the efficacy of CTN in adults ages with ADHD and comorbid...

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.Enrolling: 30820 locations
ADHDAnxietyGeneralized Anxiety+1
RECRUITINGPhase 3NCT06894212

A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia

Evaluate the efficacy and safety of Ulotaront (SEP-363856) in acutely psychotic subjects with schizophrenia

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.Enrolling: 52220 locations
Schizophrenia
RECRUITINGPhase 3NCT06971731

A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phenylketonuria (PKU)

The goal of this Phase 3, randomized study is to assess the safety, efficacy, tolerability, and pharmacokinetics (PK) of oral JNT-517 in adults (18 years of age or older) with...

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.Enrolling: 12020 locations
Phenylketonuria
RECRUITINGPhase 2NCT06637514

A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria

The goal of this Phase 2, randomized study is to assess the safety, tolerability, and pharmacokinetics (PK) of oral JNT-517 in adolescents (12 to less than 18 years of age) with...

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.Enrolling: 101 location
Phenylketonuria (PKU)